With delicious aromas wafting from the kitchen and holiday cheer all around, there’s nothing better than spending Thanksgiving at home among loved ones. However, if you’re stranded at
A downtrending market is troublesome for investors, but does present interesting opportunities through creation of lower valuations. Finding the right names in the wobbly life sciences environment
2013 was a banner year for the life sciences sector, with biotech, pharmaceutical and medtech companies buoyed by advances in therapeutic techniques, a friendly regulatory environment, lucrative
Based in Cambridge, MA, Agios Pharmaceuticals (AGIO) scheduled a $75 million IPO with a market capitalization of $441 million at a price range mid-point of $15, for Wednesday, July 24, 2013. SIx
